(Q56896703)

English

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

scientific article published on 06 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

Massimo Aglietta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Celeste Cagnazzo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

C Barone

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M B Sawyer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M J Moore

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

W H Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

C Bagalà

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

F Colombi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

L Gioeni

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

E Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

B Huang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

K D Fly

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

F Leone

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

0 references

publication date

6 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1750-1755

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Phase I/II trial of tremelimumab in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU205

21 January 2018

Identifiers

10.1093/ANNONC/MDU205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907635%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56896703&oldid=2177482956"